The gut-selective alpha4beta7 integrin antibody vedolizumab is safe and effective for long-term use in patients with inflammatory bowel disease. Medscape Medical News
Read More
Vedolizumab Shows Long-Term Safety, Efficacy

Select Page
Posted by Arden Mcnaught | Oct 9, 2020 | Health & Medical | 0 |
The gut-selective alpha4beta7 integrin antibody vedolizumab is safe and effective for long-term use in patients with inflammatory bowel disease. Medscape Medical News
Read More
Recent Comments